Cargando…

Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides

Natural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration...

Descripción completa

Detalles Bibliográficos
Autores principales: Henaux, Loïc, Pereira, Karina Danielle, Thibodeau, Jacinthe, Pilon, Geneviève, Gill, Tom, Marette, André, Bazinet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305187/
https://www.ncbi.nlm.nih.gov/pubmed/34357178
http://dx.doi.org/10.3390/membranes11070528
_version_ 1783727514223378432
author Henaux, Loïc
Pereira, Karina Danielle
Thibodeau, Jacinthe
Pilon, Geneviève
Gill, Tom
Marette, André
Bazinet, Laurent
author_facet Henaux, Loïc
Pereira, Karina Danielle
Thibodeau, Jacinthe
Pilon, Geneviève
Gill, Tom
Marette, André
Bazinet, Laurent
author_sort Henaux, Loïc
collection PubMed
description Natural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration membrane (EDUF), and to identify peptides responsible for these bioactivities. Two EDUF configurations (1 and 2) were used to concentrate anionic and cationic peptides, respectively. After EDUF separation, two fractions demonstrated interesting properties: the initial fraction of the EDUF configuration 1 and the final fraction of the EDUF configuration 2 both showed biological activities to (1) increase glucose uptake in L6 muscle cells in insulin condition at 1 ng/mL (by 12% and 21%, respectively), (2) decrease hepatic glucose production in hepatic cells at 1 ng/mL in basal (17% and 16%, respectively), and insulin (25% and 34%, respectively) conditions, and (3) decrease LPS-induced inflammation in macrophages at 1 g/mL (45% and 30%, respectively). More impressive, the initial fraction of the EDUF configuration 1 (45% reduction) showed the same effect as the phenformin at 10 μM (40%), a drug used to treat T2D. Thirteen peptides were identified, chemically synthesized, and tested in-vitro for these three bioactivities. Thus, four new bioactive peptides were identified: IPVE increased glucose uptake by muscle cells, IVDI and IEGTL decreased hepatic glucose production (HGP) of insulin, whereas VAPEEHPTL decreased HGP under both basal condition and in the presence of insulin. To the best of our knowledge, this is the first time that (1) bioactive peptide fractions generated after separation by EDUF were demonstrated to be bioactive on three different criteria; all involved in the T2D, and (2) potential sequences involved in the improvement of glucose uptake and/or in the regulation of HGP were identified from a salmon protein hydrolysate.
format Online
Article
Text
id pubmed-8305187
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83051872021-07-25 Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides Henaux, Loïc Pereira, Karina Danielle Thibodeau, Jacinthe Pilon, Geneviève Gill, Tom Marette, André Bazinet, Laurent Membranes (Basel) Article Natural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration membrane (EDUF), and to identify peptides responsible for these bioactivities. Two EDUF configurations (1 and 2) were used to concentrate anionic and cationic peptides, respectively. After EDUF separation, two fractions demonstrated interesting properties: the initial fraction of the EDUF configuration 1 and the final fraction of the EDUF configuration 2 both showed biological activities to (1) increase glucose uptake in L6 muscle cells in insulin condition at 1 ng/mL (by 12% and 21%, respectively), (2) decrease hepatic glucose production in hepatic cells at 1 ng/mL in basal (17% and 16%, respectively), and insulin (25% and 34%, respectively) conditions, and (3) decrease LPS-induced inflammation in macrophages at 1 g/mL (45% and 30%, respectively). More impressive, the initial fraction of the EDUF configuration 1 (45% reduction) showed the same effect as the phenformin at 10 μM (40%), a drug used to treat T2D. Thirteen peptides were identified, chemically synthesized, and tested in-vitro for these three bioactivities. Thus, four new bioactive peptides were identified: IPVE increased glucose uptake by muscle cells, IVDI and IEGTL decreased hepatic glucose production (HGP) of insulin, whereas VAPEEHPTL decreased HGP under both basal condition and in the presence of insulin. To the best of our knowledge, this is the first time that (1) bioactive peptide fractions generated after separation by EDUF were demonstrated to be bioactive on three different criteria; all involved in the T2D, and (2) potential sequences involved in the improvement of glucose uptake and/or in the regulation of HGP were identified from a salmon protein hydrolysate. MDPI 2021-07-14 /pmc/articles/PMC8305187/ /pubmed/34357178 http://dx.doi.org/10.3390/membranes11070528 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Henaux, Loïc
Pereira, Karina Danielle
Thibodeau, Jacinthe
Pilon, Geneviève
Gill, Tom
Marette, André
Bazinet, Laurent
Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
title Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
title_full Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
title_fullStr Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
title_full_unstemmed Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
title_short Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
title_sort glucoregulatory and anti-inflammatory activities of peptide fractions separated by electrodialysis with ultrafiltration membranes from salmon protein hydrolysate and identification of four novel glucoregulatory peptides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305187/
https://www.ncbi.nlm.nih.gov/pubmed/34357178
http://dx.doi.org/10.3390/membranes11070528
work_keys_str_mv AT henauxloic glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides
AT pereirakarinadanielle glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides
AT thibodeaujacinthe glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides
AT pilongenevieve glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides
AT gilltom glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides
AT maretteandre glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides
AT bazinetlaurent glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides